Aclaris Therapeutics (ACRS) EBT Margin (2017 - 2026)
Aclaris Therapeutics (ACRS) recorded EBT Margin of -1379.80% in Q2 2026, down 457.46 percentage points from -922.34% a year earlier and down 343.83 percentage points from the prior quarter.
Powered by 
Analysis
Aclaris Therapeutics (ACRS) EBT Margin (2017 - 2026) Analysis & Trends
On a TTM basis, Aclaris Therapeutics' EBT Margin came in at -968.31% as of Jun 30, 2026, down 144.19 percentage points year-over-year; for FY2025, it was -878.33%, down 172.85 percentage points from FY2024.
- Annual EBT Margin has a five-year change of -86.35 percentage points (FY2020 to FY2025).
- Across earlier years, EBT Margin came in at -705.48% in FY2024 (-421.15 pp), -284.32% in FY2023 (+7.79 pp), -292.11% in FY2022 (+1051.85 pp) and -1343.96% in FY2021 (-551.98 pp).
- Quarterly EBT Margin has ranged from -1702.25% in Q2 2023 to -10.57% in Q4 2023 over the past five years.
- On a year-over-year basis, EBT Margin rose in two of the last eight quarters, with an average year-over-year change of -385.04 percentage points.
- Peak year-over-year performance for EBT Margin in the last five years was a gain of 1305.07 percentage points in Q2 2024, against a drop of 1048.72 percentage points in Q4 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at -1035.97% (Q1 2026), -1629.34% (Q4 2025) and -464.69% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 34.46% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 0.13% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 27.75% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 30.74% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 26.27% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 45.21% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 36.90% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 20.41% |
| 10 | Aclaris Therapeutics | 625.92 Mn | 223.91 Mn | 1.29 Mn | -1,316.34% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -1,316.34% |
| Jun 30, 2026 | -1,379.80% |
| Mar 31, 2026 | -1,035.97% |
| Dec 31, 2025 | -1,629.34% |
| Sep 30, 2025 | -464.69% |
| Jun 30, 2025 | -922.34% |
| Mar 31, 2025 | -1,094.02% |
| Dec 31, 2024 | -1,059.30% |
| Sep 30, 2024 | -195.12% |
| Jun 30, 2024 | -397.18% |
| Mar 31, 2024 | -706.46% |
| Dec 31, 2023 | -10.57% |
| Sep 30, 2023 | -315.24% |
| Jun 30, 2023 | -1,702.25% |
| Mar 31, 2023 | -1,183.47% |
| Dec 31, 2022 | -375.07% |
| Sep 30, 2022 | -109.76% |
| Jun 30, 2022 | -1,373.95% |
| Mar 31, 2022 | -1,301.24% |
| Dec 31, 2021 | -1,525.18% |
API Access
Aclaris Therapeutics EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=ACRS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "ACRS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=ACRS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();